-
Making Collaboration More Common for Rare CancersAn AACR Annual Meeting 2022 session highlights the impact of research advocacy partnerships for a variety of cancers.
by Marci A. Landsmann
-
Second DCIS Diagnoses May Not Be Related to Initial LesionDNA sequencing found that in many cases when DCIS recurred, the lesion was unrelated to the first diagnosis, raising questions about how to best treat recurrence.
by Eric Fitzsimmons
-
Forward Look
Adequate RepresentationMedical oncologist Lola Fashoyin-Aje describes the Food and Drug Administration’s efforts to make clinical trials more inclusive.
by Erin O'Donnell
-
Forward Look
Comparing Antibody-Drug Conjugates for Metastatic Breast CancerResults favor Enhertu for treating metastatic breast cancer that recurs or does not respond to first-line treatment.
by Kris Conner
-
Forward Look
Who Benefits From Immunotherapy?Success of immune checkpoint inhibitors in clinical trials does not always carry over to patients in the clinic.
by Delia O'Hara
-
Forward Look
What’s Next?Artificial intelligence may help to classify colorectal polyps.
by Nancy Averett
-
Forward Look
Fasting-Mimicking Diet Increases Anti-Tumor ImmunityResearch suggests short bursts of intense calorie restriction could improve treatment response in patients with a range of cancers.
by Robin Donovan
-
Forward Look
Coordination of CarePilot program emphasizes standards to streamline patient care.
by Carolyn Bernhardt
-
How COVID-19 Changed Cancer CareA new report from the American Association for Cancer Research explores how the COVID-19 pandemic affected cancer patients, researchers and care providers.
by Eric Fitzsimmons
-
2021: The Year in Cancer NewsThe Cancer Today editorial staff selects some of the most impactful reporting and essays of 2021.
by Cancer Today Staff
More than half of patients who participated in a program offering online second opinions were recommended a change to their treatment plan.
by Eric Fitzsimmons
Musical Toxicity an Effect of Cancer TreatmentStudy finding cancer treatment affects ability to play or sing music highlights need for physical therapy, experts say.
by Kyle Bagenstose
Treatment Lags Behind Guidelines for Many Men With Prostate CancerGuidelines for treating advanced prostate cancer changed in 2017, but a recent study indicated many patients were not being treated accordingly.
by Laura Gesualdi Gilmore
Treating HER2-ultralow Breast CancerFDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
